广誉远中药股份有限公司 关于董事会延期换届及部分独立董事任期届满的提示性公告

Group 1 - The company's eighth board of directors will expire on January 17, 2026, and the board's election work is still in preparation, leading to a postponement of the board's renewal [2] - To ensure continuity and stability, the terms of the board's special committees and senior management will be extended accordingly until the board's election is completed [2] - The current independent director, Zhao Xuanmin, has served since January 15, 2020, and will reach the six-year limit for continuous service, but will continue to fulfill his duties until new independent directors are elected [3] Group 2 - The postponement of the board's renewal will not affect the company's normal operations, and the company will actively promote related work and fulfill its information disclosure obligations in a timely manner [4]